Shandong Xinhua Pharmaceutical Co., Ltd. (00719.HK) received the National Medical Products Administration's approval to issue the "Drug Supplement Application Approval Notice" for methylcobalamin tablets.

Zhtng Cijng APP News, Shndng Xnhu Zhyo Gfn (00719.HK) issued an announcement. Recently, the company has received the approval notice for the supplementary application of methylcobalamin tablets (referred to as the "product" below) issued by the National Medical Products Administration, approving the transfer of the supplementary application for the marketing authorization holder of the product.